The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients ; volume:28 ; number:1 ; day:03 ; month:7 ; year:2009 ; pages:1-6 ; date:12.2009
Journal of experimental & clinical cancer research ; 28, Heft 1 (03.7.2009), 1-6, 12.2009
- Creator
-
Calikusu, Zuleyha
Yildirim, Yesim
Akcali, Zafer
Sakalli, Hakan
Bal, Nebil
Unal, Ilker
Ozyilkan, Ozgur
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-9966-28-97
- URN
-
urn:nbn:de:101:1-2019111800261893781573
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Calikusu, Zuleyha
- Yildirim, Yesim
- Akcali, Zafer
- Sakalli, Hakan
- Bal, Nebil
- Unal, Ilker
- Ozyilkan, Ozgur
- SpringerLink (Online service)
Other Objects (12)
Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experience
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
Cisplatin based chemotherapy in patients with advanced differentiated thyroid carcinoma refractory to I131 treatment
Chemotherapy for Advanced Non-Small Cell Lung Cancer: Quest for the Best Continues
Perioperative chemotherapy with nivolumab for HER2-negative locally advanced gastric cancer: a case series
A Retrospective Non-Randomized Comparative Analysis of Experience with two Cisplatin Based Regimens in First Line Combination Chemotherapy for Advanced Non-Small Cell Lung Cancer
Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
Cisplatin-functionalized silica nanoparticles for cancer chemotherapy
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer
Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experience
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
Cisplatin based chemotherapy in patients with advanced differentiated thyroid carcinoma refractory to I131 treatment
Chemotherapy for Advanced Non-Small Cell Lung Cancer: Quest for the Best Continues
Perioperative chemotherapy with nivolumab for HER2-negative locally advanced gastric cancer: a case series
A Retrospective Non-Randomized Comparative Analysis of Experience with two Cisplatin Based Regimens in First Line Combination Chemotherapy for Advanced Non-Small Cell Lung Cancer
Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
Cisplatin-functionalized silica nanoparticles for cancer chemotherapy
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer
Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experience
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
Cisplatin based chemotherapy in patients with advanced differentiated thyroid carcinoma refractory to I131 treatment
Chemotherapy for Advanced Non-Small Cell Lung Cancer: Quest for the Best Continues
Perioperative chemotherapy with nivolumab for HER2-negative locally advanced gastric cancer: a case series
A Retrospective Non-Randomized Comparative Analysis of Experience with two Cisplatin Based Regimens in First Line Combination Chemotherapy for Advanced Non-Small Cell Lung Cancer
Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
Cisplatin-functionalized silica nanoparticles for cancer chemotherapy
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer